三阴性乳腺癌免疫治疗的进展与展望
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
31.3分
★☆☆☆☆
站内排序·非疗效
ALL SOURCES
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。